Suicidality Link Seen In Columbia Univ. Meta-Analysis Of Antidepressant Data
This article was originally published in The Pink Sheet Daily
Executive Summary
A Columbia University meta-analysis found a statistically significant link between suicidality and pediatric antidepressant drug use, a memo from FDA Division of Drug Risk Evaluation Epidemiologist Andrew Mosholder, MD, states
You may also be interested in...
Antidepressant Suicidality Class Risk Will Be Reviewed By Advisory Committees
FDA releases analysis of pediatric suicidality data for joint meeting of Psychopharmacologic Drugs and Pediatric Advisory Committees. The analysis could result in label changes for antidepressants, FDA Talk Paper says.
FDA Antidepressant Suicide Report May Have Been Suppressed – Sen. Grassley
Senate Finance Committee staffers are requesting a meeting with FDA to discuss the alleged suppression of an internal report on suicide-related events in children taking antidepressants.
Lupus Guidance Suggests Broad Use Of Health-Related Quality Of Life Endpoint
FDA’s draft guidance on systemic lupus erythematosus drug development lists four possible claims that the agency “may be willing to approve”: reduction in disease activity; organ-specific lupus treatment; complete clinical response/remission; and reduction in flares.